Abstract
Treatment-Free Remission Accomplished By Dasatinib (TRAD): Preliminary Results of the Pan-Canadian Tyrosine Kinase Inhibitor Discontinuation Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have